A MEDICAL cannabis company with a focus on providing high quality and affordable products for Australian customers has seen an increase in uptake in recent years, as local customers jump on board the potential healing properties.
In 2017, Little Green Pharma (LGP), a WA-based company, received Australia’s third ever cultivation licence for medical cannabis and set about building two small grow rooms in the South West.
LGP partnered up with an existing good manufacturing practice (GMP) which was already manufacturing medicines of the same schedule of drug, such as opioid style medications, for hospitals in WA.
Partnering with a third party manufacturer helped to take a huge chunk of time off delivering their first product and in August 2018, LGP released the very first Australian produced medical cannabis products for patient use.
LGP chief operations officer Paul Long said in the beginning the company wanted to prove the concept and chose to start small.
“A couple of the other companies…
